INS and obesity disorder: Similarly, renin inhibition with aliskiren improves insulin sensitivity, skeletal muscle glucose uptake, glucose tolerance, and insulin secretion in male rodent models of hypertension, diabetes, obesity, and metabolic syndrome [44–48].